Navigation Links
Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Date:10/1/2009

te500®, which uses HIFU for the treatment of prostate cancer in Europe. We have expanded our sales force and added to our distribution network in Italy, Russia, Portugal, Romania, and Bulgaria.

As you know, we have been developing expertise in the exciting new area of High Intensity Focused Ultrasound ("HIFU"). To continue to be a leader in this field, we purchased HIFU related intellectual property that we believe will enable us to develop and manufacture new HIFU transducers. With the development of new transducers, we may be able to increase the type of tissue we can affect beyond our present rights in kidney, liver and breast.

We are continuing to complete clinical evaluation procedures using HIFU for the treatment of kidney tumors at the University of Vienna in Austria. We have received our second 510k in the United States for this treatment.

We are excited about the growth opportunities for our innovative ultrasonic medical device business. With a strengthened balance sheet, exciting new products, a new direct salesforce and broad based international distribution we believe that fiscal year 2010 will be one of growth and expansion for your Company."

Conference Call

Misonix management will host a conference call and webcast on Thursday, October 1, 2009 at 4:30 pm ET to discuss the Company's fourth quarter fiscal 2009 financial results.

The conference call will be broadcast live via the Investor Relations section of the Company's Web site at www.misonix.com. Alternatively, participants may join the conference call by dialing (866) 515-2909 (domestic) or (617) 399-5123 (international) and entering access code 61977194, a few minutes before the start of the call.

For those unable to attend the live results broadcasts, a recording of the live-call will be available approximately 2 hours after the event through October 8, 2009. The dial-i
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... BETHESDA, Md. , May 28, 2015 /PRNewswire-USNewswire/ ... that it will be a supporting organization of ... assurance and sterilization in 2016. Johnson ... a series of high-profile superbug infections in endoscopes. ... world health issues between 1976 and 2003 on ...
(Date:5/28/2015)... 2015   Mast Therapeutics, Inc. (NYSE ... molecular adhesion and sealant technology (MAST) platform to ... failure, and arterial disease, today announced that Jack ... of Directors. Mr. Lief made this decision to ... role as President and Chief Executive Officer of ...
(Date:5/28/2015)... -- Compassion & Choices today is pleased to report that ... authorize the option of medical aid in dying for terminally ... The legislation, the End of ... adults with six months or less to live the option ... peacefully end an unbearable dying process. A vote on the ...
Breaking Medicine Technology:PDA Announces Support for the Johnson & Johnson Kilmer Conference 2Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3
... Ind., Oct. 18, 2011 ... biopharmaceutical cGMP storage, supply chain management, prescription drug ... they have signed a five-year contract with the ... Supply Schedule, Logistics Worldwide (LogWorld). Inclusion on this ...
... YORK, Oct. 18, 2011 Reportlinker.com announces ... available in its catalogue: ... to 2015 http://www.reportlinker.com/p0535967/The-Global-Pharmaceutical-Fine-Chemicals-Market-Outlook-to-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Chemical_and_Material ... This report provides a comprehensive overview ...
Cached Medicine Technology:Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X 2Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X 3The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 2The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 3The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 4The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 5
(Date:5/29/2015)... Diego, CA (PRWEB) May 29, 2015 The ... Diego plumbing , heating & air conditioning and restoration ... they have maintained value, ethics and commitment to giving back ... Diego plumber two years in a row from the Union ... the San Diego Business Journal (SDBJ), multi-year recognition as a ...
(Date:5/29/2015)... Belviq for weight loss , also ... medication. In 2012, the FDA approved Belviq specifically ... BMI >30. It is also approved for individuals ... weight-related health condition such as high blood pressure, diabetes, ... for weight loss focuses on the brain’s appetite center. ...
(Date:5/28/2015)... Medical Device Cybersecurity Quality Assurance: ... Webinar**, June 23, 2015 — 1:00 p.m. – ... connectivity opens up a wealth of possibilities for ... of potential liabilities. Devices transmit data on the ... be sure the information doesn’t fall into unauthorized ...
(Date:5/28/2015)... Recently, KORT Richmond, 5006 Atwood Drive, added a new ... life. The program works with those new to prosthetic devices ... are still having difficulty. , According to the Amputee ... limb loss in the United States. The main causes of ... arterial disease – trauma (45%) and cancer (less than 2%), ...
(Date:5/28/2015)... May 28, 2015 Cosmetic Town Journal ... surgeons and patients alike. You can find information on ... and body contouring. Readers can directly connect to the ... experience from the ground up. , The continued addition ... the community to grow and getting it closer to ...
Breaking Medicine News(10 mins):Health News:Bill Howe Plumbing Business Development Director Honored for Contribution to Woman in Industry 2Health News:Bill Howe Plumbing Business Development Director Honored for Contribution to Woman in Industry 3Health News:Belviq for Weight Loss is Now Available to Qualified Diet Doc Patients Nationwide 2Health News:Belviq for Weight Loss is Now Available to Qualified Diet Doc Patients Nationwide 3Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 2Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 3Health News:KORT Richmond Physical Therapy Adds New Program to Help Amputees 2Health News:New York Cosmetic Doctors Now in Cosmetic Town 2Health News:New York Cosmetic Doctors Now in Cosmetic Town 3
... youth aged 8 to 18 consume an average of 13 ... more than their white counterparts, according to a Northwestern University ... media use by race and ethnicity. "In the past ... use has doubled for blacks and quadrupled for Hispanics," says ...
... , TUESDAY, June 7 (HealthDay News) -- As a deadly ... health officials announced Tuesday that salmonella, not E. coli, remains ... while rates of several types of foodborne illness -- including ... 15 years, there,s been no progress against salmonella infections, according ...
... influenza vaccine targeting a protein common to all strains ... in humans. If proven effective, the vaccine could eliminate ... to match predicted strains, with major implications for global ... led by the University of Texas Medical Branch at ...
... As warm weather arrives and the great outdoors beckons, more ... trails, the beaches, or their yards and gardens, embarking on ... While it may be tempting to ignore these aches and ... wiser choice is to visit a physician who can determine ...
... Children who survive cancer are more likely to develop another ... cancer survivors found. Researchers followed 17,981 cancer survivors ... 25 years. During that time, 1,354 new tumors (neoplasms) were ... the study revealed, involved the central nervous system, followed by ...
... French . Montreal, June 7, 2011 Sex ... to a new report published in the Canadian Review of ... the study calls for sweeping changes to sex work performed on ... our laws, we must also revamp our attitudes and implement policies ...
Cached Medicine News:Health News:Study: Stark differences in media use between minority and white youth 2Health News:Study: Stark differences in media use between minority and white youth 3Health News:Study: Stark differences in media use between minority and white youth 4Health News:In U.S., Salmonella Is on the Rise While E. Coli Retreats 2Health News:In U.S., Salmonella Is on the Rise While E. Coli Retreats 3Health News:In U.S., Salmonella Is on the Rise While E. Coli Retreats 4Health News:Universal flu vaccine clinical trials show promise 2Health News:Universal flu vaccine clinical trials show promise 3Health News:Bursitis a common cause of painful hips, knees, heels and elbows 2Health News:Bursitis a common cause of painful hips, knees, heels and elbows 3Health News:Childhood Cancer Survivors at Greater Risk for Tumors as Adults 2Health News:Dangerous and under the radar 2Health News:Dangerous and under the radar 3
Anterior Stromal Puncture Cannula, 25 g. For treatment of recurrent corneal erosion. Overall length 24 mm. 5/box....
Viscoelastic Cannula, 23 g. Angled. 7 mm angled tip cannula with unique hub that facilitates flow of viscoelastic material. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 21 g., 8 mm from bend to tip. Overall length 25 mm. 5/box....
Anterior Chamber Needle, 25 g. Angled. 9 mm angled tip. Overall length 19 mm. 5/box....
Medicine Products: